Kanta Kon
Sugitani, 9300194, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.
Journal: European journal of pharmacology
Published: August 11, 2023
Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity.
Journal: Cell reports
Published: December 17, 2021
Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice.
Journal: International journal of biological sciences
Published: August 20, 2021
Human adipose tissue is a putative direct target of daytime orexin with favorable metabolic effects: A cross-sectional study.
Journal: Obesity (Silver Spring, Md.)
Published: April 08, 2021
Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice.
Journal: The Journal of endocrinology
Published: July 18, 2019
Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice.
Journal: Diabetes
Published: September 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026